Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04299867 · ClinicalTrials.gov registry record
Perioperative Tissue Penetration of Antimicrobials in Infants
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 21
- Enrollment target
NCT04299867: Completed study, sponsored by Duke University.
NCT04299867 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04299867 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This study aims to define the pharmacokinetic (PK) properties of a commonly used antibiotic to treat cIAI, metronidazole, in the intestinal wall tissue of healthy infants undergoing intestinal surgery to optimize intestinal wall penetration of antibiotics in infants. Metronidazole will be given at standard of care intravenous loading dose of 30 mg/kg 15 minutes prior to incision, with a maximum dose of 2g. Intraoperative plasma samples will be obtained from pre-existing vascular access catheters at end of bolus, 30, 60, 90 minutes, at time of intestinal excision, and at the end of the case in ethylenediaminetetraacetic acid microcontainers, exceeding no more than 5mL total.
Interventions
- PROCEDURE Bowel Surgery with Metronidazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2022-04-25 |
What the finished NCT04299867 record still lists
NCT04299867 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Bowel Surgery with Metronidazole is the first listed.
NCT04299867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04299867 about?
NCT04299867 is a clinical study titled "Perioperative Tissue Penetration of Antimicrobials in Infants". This study aims to define the pharmacokinetic (PK) properties of a commonly used antibiotic to treat cIAI, metronidazole, in the intestinal wall tissue of healthy infants undergoing intestinal surgery to optimize intestinal wall penetration of antibiotics in infants. Metronidazole will be given at s...
What is the current status of trial NCT04299867?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2020-07-15. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT04299867?
The interventions under investigation include: Bowel Surgery with Metronidazole (PROCEDURE).
Who is sponsoring clinical trial NCT04299867?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI